• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核受体辅阻遏物(N-CoR)包含三个异亮氨酸基序(I/LXXII),它们作为受体相互作用结构域(ID)。

The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).

作者信息

Webb P, Anderson C M, Valentine C, Nguyen P, Marimuthu A, West B L, Baxter J D, Kushner P J

机构信息

Metabolic Research Unit, University of California School of Medicine, San Francisco 94143-0540, USA.

出版信息

Mol Endocrinol. 2000 Dec;14(12):1976-85. doi: 10.1210/mend.14.12.0566.

DOI:10.1210/mend.14.12.0566
PMID:11117528
Abstract

Unliganded thyroid hormone receptors (TRs) repress transcription through recruitment of corepressors, including nuclear receptor corepressor (N-CoR). We find that N-CoR contains three interaction domains (IDs) that bind to TR, rather than the previously reported two. The hitherto unrecognized ID (ID3) serves as a fully functional TR binding site, both in vivo and in vitro, and may be the most important for TR binding. Each ID motif contains a conserved hydrophobic core (I/LXXII) that resembles the hydrophobic core of nuclear receptor boxes (LXXLL), which mediates p160 coactivator binding to liganded nuclear receptors. Although the integrity of the I/LXXII motif is required for ID function, substitution of ID isoleucines with leucines did not allow ID peptides to bind to liganded TR, and substitution of NR box leucines with isoleucines did not allow NR box peptides to bind unliganded TR. This indicates that the binding preferences of N-CoR for unliganded TR and p160s for liganded TR are not dictated solely by the identity of conserved hydrophobic residues within their TR binding motifs. Examination of sequence conservation between IDs, and mutational analysis of individual IDs, suggests that they are comprised of the central hydrophobic core and distinct adjacent sequences that may make unique contacts with the TR surface. Accordingly, a hybrid peptide that contains distinct adjacent sequences from ID3 and ID1 shows enhanced binding to TR.

摘要

未结合配体的甲状腺激素受体(TRs)通过募集包括核受体辅阻遏物(N-CoR)在内的辅阻遏物来抑制转录。我们发现N-CoR包含三个与TR结合的相互作用结构域(IDs),而非先前报道的两个。迄今未被识别的ID(ID3)在体内和体外均作为一个功能完备的TR结合位点,且可能对TR结合最为重要。每个ID基序都包含一个保守的疏水核心(I/LXXII),其类似于核受体框(LXXLL)的疏水核心,后者介导p160共激活因子与结合配体的核受体结合。尽管I/LXXII基序的完整性是ID功能所必需的,但将ID中的异亮氨酸替换为亮氨酸并不允许ID肽与结合配体的TR结合,而将核受体框中的亮氨酸替换为异亮氨酸也不允许核受体框肽与未结合配体的TR结合。这表明N-CoR对未结合配体的TR的结合偏好以及p160s对结合配体的TR的结合偏好并非仅由其TR结合基序内保守疏水残基的特性所决定。对IDs之间序列保守性的研究以及对单个IDs的突变分析表明,它们由中央疏水核心和可能与TR表面形成独特接触的不同相邻序列组成。因此,一种包含来自ID3和ID1不同相邻序列的杂合肽显示出与TR的结合增强。

相似文献

1
The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).核受体辅阻遏物(N-CoR)包含三个异亮氨酸基序(I/LXXII),它们作为受体相互作用结构域(ID)。
Mol Endocrinol. 2000 Dec;14(12):1976-85. doi: 10.1210/mend.14.12.0566.
2
Molecular determinants required for selective interactions between the thyroid hormone receptor homodimer and the nuclear receptor corepressor N-CoR.甲状腺激素受体同源二聚体与核受体共抑制因子 N-CoR 之间选择性相互作用所需的分子决定因素。
J Mol Biol. 2010 Feb 26;396(3):747-60. doi: 10.1016/j.jmb.2009.12.008. Epub 2009 Dec 16.
3
E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode.E1A和一种核受体共抑制因子剪接变体(N-CoRI)是以共抑制模式结合的甲状腺激素受体共激活因子。
Proc Natl Acad Sci U S A. 2005 May 3;102(18):6267-72. doi: 10.1073/pnas.0501491102. Epub 2005 Apr 22.
4
Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.核受体共抑制因子与甲状腺激素受体相互作用的测定
Mol Endocrinol. 2003 Feb;17(2):273-86. doi: 10.1210/me.2002-0310.
5
TR surfaces and conformations required to bind nuclear receptor corepressor.与核受体共抑制因子结合所需的TR表面和构象。
Mol Endocrinol. 2002 Feb;16(2):271-86. doi: 10.1210/mend.16.2.0777.
6
Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.核激素受体共抑制因子RIP13/N-CoR中的两个受体相互作用结构域。
Mol Endocrinol. 1996 Dec;10(12):1646-55. doi: 10.1210/mend.10.12.8961273.
7
The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.CoRNR基序通过核激素受体控制共抑制因子的募集。
Nature. 1999 Nov 4;402(6757):93-6. doi: 10.1038/47069.
8
Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).核受体共抑制因子(N-CoR)中LXXLL基序的功能分析。
J Steroid Biochem Mol Biol. 2004 Aug;91(4-5):191-6. doi: 10.1016/j.jsbmb.2004.04.006.
9
Direct interactions between corepressors and coactivators permit the integration of nuclear receptor-mediated repression and activation.共抑制因子与辅激活因子之间的直接相互作用允许核受体介导的抑制与激活的整合。
Mol Endocrinol. 2002 Jul;16(7):1482-91. doi: 10.1210/mend.16.7.0860.
10
The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.核激素受体与共抑制因子之间相互作用的特异性是由相互作用结构域内不同的氨基酸序列介导的。
Mol Endocrinol. 2001 Jul;15(7):1049-61. doi: 10.1210/mend.15.7.0669.

引用本文的文献

1
Transcriptional Cofactors for Thyroid Hormone Receptors.甲状腺激素受体的转录辅因子
Endocrinology. 2025 Jan 6;166(2). doi: 10.1210/endocr/bqae164.
2
Receptor modulators associated with the hypothalamus -pituitary-thyroid axis.与下丘脑 - 垂体 - 甲状腺轴相关的受体调节剂。
Front Pharmacol. 2023 Dec 4;14:1291856. doi: 10.3389/fphar.2023.1291856. eCollection 2023.
3
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists and .发现并基于结构设计强效共价 PPARγ 反向激动剂 及 。
J Med Chem. 2022 Nov 10;65(21):14843-14863. doi: 10.1021/acs.jmedchem.2c01379. Epub 2022 Oct 21.
4
Nuclear Receptor Coregulators in Hormone-Dependent Cancers.激素依赖性癌症中的核受体共调节因子
Cancers (Basel). 2022 May 13;14(10):2402. doi: 10.3390/cancers14102402.
5
Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet ( L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet.珍珠粟(L.)谷物及其乙醇提取物对高脂饮食大鼠的抗高血脂、降血糖和保肝作用。
Nutrients. 2022 Apr 25;14(9):1791. doi: 10.3390/nu14091791.
6
Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor.抗击炎症:糖皮质激素受体调节炎症基因的机制。
Front Immunol. 2019 Aug 7;10:1859. doi: 10.3389/fimmu.2019.01859. eCollection 2019.
7
The nuclear receptor superfamily: A structural perspective.核受体超家族:结构视角。
Protein Sci. 2018 Nov;27(11):1876-1892. doi: 10.1002/pro.3496.
8
Ubiquitin specific protease 19 involved in transcriptional repression of retinoic acid receptor by stabilizing CORO2A.泛素特异性蛋白酶19通过稳定CORO2A参与视黄酸受体的转录抑制。
Oncotarget. 2016 Jun 7;7(23):34759-72. doi: 10.18632/oncotarget.8976.
9
Nuclear receptor full-length architectures: confronting myth and illusion with high resolution.核受体全长结构:以高分辨率直面神话与幻象
Trends Biochem Sci. 2015 Jan;40(1):16-24. doi: 10.1016/j.tibs.2014.10.011. Epub 2014 Nov 28.
10
Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.癌症中的核受体共抑制复合物:机制、功能与调控
Am J Clin Exp Urol. 2014 Oct 2;2(3):169-87. eCollection 2014.